Text Size

Physical Activity Behavior of Rheumatoid Arthritis Patients and Healthy Controls

This study has been completed.
Sponsor:
Information provided by:
University of Lausanne
ClinicalTrials.gov Identifier:
NCT01228812
First received: October 26, 2010
Last updated: NA
Last verified: October 2010
History: No changes posted
  Purpose

The purpose of the study is to compare physical activity behaviour of rheumatoid arthritis patients with healthy matched controls.


Condition
Rheumatoid Arthritis

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: An Observational Study of Physical Activity Behavior of Swiss Rheumatoid Arthritis Patients and Healthy Matched Controls

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Lausanne:

Primary Outcome Measures:
  • Physical activity [ Designated as safety issue: No ]
    PAFQ


Secondary Outcome Measures:
  • Functional status [ Designated as safety issue: No ]
    HAQ

  • Pain [ Designated as safety issue: No ]
    VAS

  • Fatigue [ Designated as safety issue: No ]
    VAS

  • Disease activity [ Designated as safety issue: No ]
    DAS 28


Study Start Date: April 2010
Study Completion Date: September 2010
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
RA patients
Patients with Rheumatoid Arthritis
Healthy subjects
Healthy subjects matched for age and sex

  Eligibility

Ages Eligible for Study:   40 Years to 80 Years
Genders Eligible for Study:   Both
Sampling Method:   Probability Sample
Study Population

Patients from the RA patients group will be selected in the Rheumatology Department of the Centre Hospitalier universitaire Vaudois in Lausanne. Healthy matched controls will be randomly selected from a cohort study conducted in Lausanne.

Criteria

Inclusion Criteria (RA patients):

  • Rheumatoid arthritis
  • Functional classes I, II and III
  • Age 40 to 80 years
  • Stable disease activity
  • Stable DMARDS last 3 months

Exclusion Criteria (RA patients):

  • Functional classes IV
  • Inflammatory flare
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01228812

Locations
Switzerland
Centre Hospitalier Universitaire Vaudois, Département de l'Appareil Locomoteur
Lausanne, Switzerland
Sponsors and Collaborators
University of Lausanne
Investigators
Study Director: Alexander KL So, PhD, FRCP Université de Lausanne, Service de Rhumatologie, Département de l'Appareil Locomoteur, Lausanne, Suisse
Principal Investigator: Yves Henchoz, PhD Université de Lausanne, Service de Rhumatologie, Département de l'Appareil Locomoteur, Lausanne, Suisse
Study Chair: Jean Dudler, PD, MER Université de Lausanne, Service de Rhumatologie, Département de l'Appareil Locomoteur, Lausanne, Suisse
Study Chair: François Bastardot, MD Etude CoLaus, Centre Hospitalier Universitaire Vaudois, Lausanne
Study Chair: Peter Vollenweider, MD Etude CoLaus, Centre Hospitalier Universitaire Vaudois, Lausanne
Study Chair: Idris Guessous, MD Unité d'Epidémiologie Populationnelle, Département de médecine communautaire et de premier recours, Hôpitaux Universitaires de Genève
  More Information

No publications provided by University of Lausanne

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

ClinicalTrials.gov Identifier: NCT01228812     History of Changes
Other Study ID Numbers: PR_AP
Study First Received: October 26, 2010
Last Updated: October 26, 2010
Health Authority: Switzerland: Ethikkommission

Keywords provided by University of Lausanne:
Rheumatoid arthritis, physical activity

Additional relevant MeSH terms:
Arthritis
Arthritis, Rheumatoid
Joint Diseases
Musculoskeletal Diseases
 Rheumatic Diseases
Connective Tissue Diseases
Autoimmune Diseases
Immune System Diseases

ClinicalTrials.gov processed this record on June 18, 2013